ENTPD1 and neuroblastoma: Interestingly, the presence of EV expressing CD38, CD39 and CD73 (but not CD203a/PC-1) in the BM correlated with a worse event-free survival of NB patients, suggesting that NB-derived EV may dampen anti-tumor immune response in vivo.